Sheridan, Jan. 09, 2026 (GLOBE NEWSWIRE) — According to the latest market report published by Wissen Research, the global Car-T Cell Therapy Market was valued at 5.2 billion in 2024. Furthermore, the market is expected to grow at a CAGR of 31 % during the forecast period from 2025 to 2030. Car-T Cell Therapy Market […]

Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook GlobeNewswire January 09, 2026 Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; seamless adaptive clinical trial offering potential opportunity for a single pivotal trial expected to commence in 1H26 Phase 1/2 pediatric

Car-T Cell Therapy market to grow at a CAGR of 31 % during the forecast period (2025 – 2030): Wissen Research The global car-t cell therapy market was valued at USD 5.2 billion in 2024 and is projected to reach USD 26.2 billion by 2030, expected to grow at a CAGR of 31 % during

— Participation underscores growing excitement around company’s momentum and potential in precision oncology iOnctura, a clinical-stage biopharmaceutical company developing precision oral small molecules for neglected and hard-to-treat cancers, today announces that its Chief Executive Officer, Catherine Pickering, will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco,

Grass Valley, California–(Newsfile Corp. – January 9, 2026) – In its September 16, 2025 press release, Rise Gold Corp. (CSE: RISE) (OTCQB: RYES) (the “Company“) announced that Nevada County (the “County”), Rise, and the Superior Court of California for the County of Nevada (the “Court”) agreed to a schedule that anticipated that oral arguments concerning

Vancouver, British Columbia–(Newsfile Corp. – January 9, 2026) – Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (“Burcon” or the “Company“), a global technology leader in plant-based protein innovation, is pleased to announce that, in response to strong demand, it has increased the size of its previously announced non-brokered private placement (the “Private Placement”) of convertible debentures (the

Vancouver, British Columbia–(Newsfile Corp. – January 9, 2026) – Antimony Resources Corp. (CSE: ATMY) (OTCQB: ATMYF) (FSE: K8J0) (the “Company” or “Antimony Resources” or “ATMY”) is pleased to present the latest set of High-Grade antimony (Sb) assays from the Bald Hill Antimony Project in New Brunswick, Canada. Assays for Drill Holes BH-25-17 to BH-25-22 are

(NASDAQ:HURC), INDIANAPOLIS, Jan. 09, 2026 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the fourth fiscal quarter and fiscal year ended October 31, 2025. Hurco recorded a net loss of $3,041,000, or $0.47 per diluted share, for the fourth quarter of fiscal year 2025, compared to a net loss of $1,442,000,

RALEIGH, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) — Attindas Hygiene Partners' growth strategy realized an important step forward today with its acquisition of Societa Italiana Lavorazione Cellulosa (SILC S.p.A.). Attindas executed a share purchase agreement with SILC, acquiring all shares of the 53-year-old, family-owned company. SILC S.p.A. serves customers throughout Europe with high-quality, absorbent hygiene

PLANEGG, Germany and MUNICH, Jan. 09, 2026 (GLOBE NEWSWIRE) — A new study published in Pharmaceutics (https://doi.org/10.3390/pharmaceutics18010050) shows that LEON's FR-JET(R) modular mixer addresses key manufacturing challenges by enabling the production of highly concentrated lipid nanoparticles (LNPs). The study demonstrates that LNP formulation at significantly higher lipid mixture concentrations, beyond those currently reported in the